The pharmaceutical industry in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This effective medication, used to treat glucose intolerance, has captured extensive attention from both individuals and healthcare professionals. As a result, numerous companies have emerged as producers of Tirzepatide APIs in the US